Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-overexpressing/amplified (HER2+) metastatic colorectal cancer (mCRC): Primary results from the multicenter, randomized, phase 2 DESTINY-CRC02 study.Kanwal Raghav, Takayuki Yoshino, Marc Peeters et al.|Journal of Clinical Oncology|2023Cited by 77
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal carcinomatosisEddy Cotte, Alex Kartheuser, Sylvie Van den Broeck et al.|DIAL (Catholic University of Leuven)|2012Cited by 0
Long term oncological results and quality of life after HIPEC for carcinomatosis of colorectal originSandrine Barbois, Alex Kartheuser, Daniel Léonard et al.|Digital Access to Libraries|2018Cited by 0
Cytoreductive surgery and hyperthermic intraperitoneal chemoetherapy for peritoneal carcinomatosis from colorectal cancer: results of the association of the closed abdomen technique combined with oxaliplatinSandrine Barbois, Alex Kartheuser, Daniel Léonard et al.|DIAL (Catholic University of Leuven)|2017Cited by 0